Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Umedica Laboratories Private Limited, is an unlisted private company incorporated on 05 January, 1982. It is classified as a private limited company and is located in Valsad, Gujarat. It's authorized share capital is INR 17.50 cr and the total paid-up capital is INR 3.11 cr.
Umedica Laboratories's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's book networth has increased by 764.62%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
370.85%
764.62%
188.66%
225.5%
3.7
11.26
9.27
42.71
27.18
-2.13
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(7)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
SBICap Trustee Company Limited
No. of Loans: 3
Total Amount : 427.2 cr
HDFC Bank Limited
No. of Loans: 3
Total Amount : 63.7 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 30.5 cr
State Bank of India
No. of Loans: 1
Total Amount : 30.0 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 22.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 9.0 cr
DBS Bank Limited
No. of Loans: 1
Total Amount : 2.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Manish Umed Doshi
Shareholder
|
00210389 | 43 years |
| Director | Vandana Manish Doshi
Shareholder
|
00211618 | 8 years |
| Director | Rupesh Suryakant Kamdar | 02358348 | 6 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| URANUS ELECTRO TECHNIK PRIVATE LIMITED |
Active
|
4.0 L | 1 | Maharashtra |
| SUJAG FINE CHEMICALS PRIVATE LIMITED |
Active
|
50.0 L | 1 | Gujarat |
| SWETA PHARMA PVT LTD |
Active
|
2.2 L | 2 | Maharashtra |
| AMOLI INFOTECH PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
| TOLSTOY INVESTMENTS PRIVATE LIMITED |
Active
|
1.3 Cr | 2 | Maharashtra |
| AMOLI INVESTMENT SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| AMOLI PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| UMEDICA INVESTMENT SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| UMEDICA PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| KMI BUSINESS TECHNOLOGIES PRIVATE LIMITED |
Active
|
5.0 L | 1 | Maharashtra |
| AMOLI ORGANICS PRIVATE LIMITED |
Amalgamated
|
5.1 Cr | 3 | Gujarat |
| URANUS ELECTRONICS PRIVATE LIMITED |
Active
|
4.0 L | 1 | Maharashtra |
| APE-AAN FINSER PRIVATE LIMITED |
Converted to LLP
|
4.2 L | 1 | Maharashtra |
| APE-AAN FINSER LLP |
Active
|
4.2 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Umedica Limited | United Kingdom | - | - |
| Umedica Netherlands BV | Netherlands | - | - |
The incorporation date of UMEDICA LABORATORIES PRIVATE LIMITED is 05 January, 1982
The authorized share capital of UMEDICA LABORATORIES PRIVATE LIMITED is INR ₹ 17.5 Cr.
The paid-up capital of UMEDICA LABORATORIES PRIVATE LIMITED is INR ₹ 3.1 Cr.
The registered address of UMEDICA LABORATORIES PRIVATE LIMITED is P. No-221,222/1, GIDC Vapi Vapi Pardi Valsad Gujarat - 396191
The CIN number of UMEDICA LABORATORIES PRIVATE LIMITED is U24231GJ1982PTC141202.
Expand
Delete
Collapse
See
details
